Johnny Yu

Johnny Yu is the Chief Scientific Officer and Co-founder of Vevo Therapeutics, a biotechnology company focused on single-cell drug discovery, utilizing an in vivo drug discovery platform and advanced AI models to develop innovative treatments. Prior to this role, Johnny Yu was a Ph.D. student in Dr. Hani Goodarzi's lab at UCSF, where research involved RNA Binding Proteins and single-cell RNA sequencing, leading to a significant publication in Cancer Discovery 2020. Earlier experiences include working as a Research Associate II at the Broad Institute, where functional characterization of GWAS-derived SNPs related to Atrial Fibrillation was conducted, and as an Associate Scientist I at Biogen Idec, focusing on technical development and downstream processes for antibody purification. Johnny Yu obtained a Ph.D. in Biomedical Sciences from the University of California, San Francisco, following a Bachelor of Science in Biochemistry from Tufts University.